×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
26619011
2016
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
GeneticVariation
CLINVAR
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
26619011
2016
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
25157968
2014
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
GeneticVariation
CLINVAR
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
25157968
2014
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system.
23888070
2013
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials.
23066039
2013
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
22162589
2012
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials.
22162582
2012
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations.
21558396
2011
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
20453058
2010
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.
18725974
2008
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.
18676830
2008
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
15647370
2005
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
We identified PIK3CA mutations in 26% of 342 human breast tumor samples and cell lines at about equal frequency in tumor stages I to IV.
15805248
2005
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
GeneticVariation
CLINVAR
We identified PIK3CA mutations in 26% of 342 human breast tumor samples and cell lines at about equal frequency in tumor stages I to IV.
15805248
2005
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
Mammary Neoplasms
0.500
CausalMutation
CLINVAR
The PIK3CA gene is mutated with high frequency in human breast cancers.
15254419
2004